Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.05.24	AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock (MotleyFool)
26.05.24	How Much Will Pfizer Pay Out in Dividends This Year? (MotleyFool)
23.05.24	Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 (Benzinga)
21.05.24	Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead? (MotleyFool)
20.05.24	Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute (Benzinga)
20.05.24	Pfizer Unusual Options Activity (Benzinga)
17.05.24	Moderna wins Covid jab patent dispute over Pfizer and BioNTech (Financial Times)
16.05.24	Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game (Benzinga)
16.05.24	Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report (Benzinga)
16.05.24	Pfizer offers up to $250mn to settle thousands of Zantac cancer lawsuits (Financial Times)
15.05.24	Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades' (Benzinga)
14.05.24	NVIDIA, Amazon, Apple & Co.: Das sind die am meisten bewunderten Unternehmen der Welt (finanzen.ch) Jedes Jahr erstellt Fortune ein Ranking mit den "World’s Most Admired Companies". In diesem Jahr kamen die Top Ten Unternehmen alle aus den USA.» mehr
13.05.24	Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients (Benzinga)
13.05.24	Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector (Benzinga)
13.05.24	Der Pharmakonzern Pfizer entlässt in Zug bis zu 74 Angestellte (Handelszeitung)
13.05.24	Massenentlassung bei Pfizer in Zug (Handelszeitung)
13.05.24	Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock (MotleyFool)
09.05.24	Spotlight on Pfizer: Analyzing the Surge in Options Activity (Benzinga)
08.05.24	Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac (Benzinga)
08.05.24	Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial (Benzinga)
06.05.24	Pfizer Announces New Chief Strategy and Innovation Officer (Businesswire)
04.05.24	Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market? (MotleyFool)
02.05.24	Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For' (Benzinga)
02.05.24	Pfizer Unusual Options Activity (Benzinga)
02.05.24	Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
02.05.24	Pfizer (PFE) Q1 2024 Earnings Call Transcript (MotleyFool)
01.05.24	Why Pfizer Stock Blasted More Than 6% Higher Today (MotleyFool)
01.05.24	Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates (Benzinga)
01.05.24	Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations (Benzinga)
01.05.24	Pfizer Reports First-Quarter 2024 Results (Businesswire)
01.05.24	Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday (Benzinga)
01.05.24	Pfizer plans direct-to-consumer platform for Covid and migraine treatments (Financial Times)
30.04.24	Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings (Benzinga)
30.04.24	Pfizer, Genmab get full FDA approval for cervical-cancer drug (MarketWatch)
30.04.24	FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten